A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Dissatisfied With Their Existing Triptan Therapy.
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Zogenix
- 28 Dec 2011 Actual patient numbers changed from 212 to 246 as reported by ClinicalTrials.gov.
- 04 Aug 2011 Secondary endpoint 'Patient confidence' has been met.
- 04 Aug 2011 Primary endpoint 'Patient-satisfaction' has been met.